Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver

Transplantation

Volumn 66, Issue 5, 1998, Pages 579-585

  Ohmori, Haruki ^a   Dhar, Dipok Kumar ^a   Nakashima, Yuichi ^a   Hashimoto, Michio ^a   Masumura, Sumio ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GRAFT PRESERVATION; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ARGININE; LIVER; MALE; NITRIC OXIDE; NITRO COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 0032530470     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809150-00005     Document Type: Article

References (47)

1. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159.
2. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischemic injury. N Engl J Med 1986; 26: 1670.
3. Marubayashi S, Takenaka M, Dohi K, Ezaki H, Kawasaki T. Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation 1980; 30: 294.
4. 10. Surgery 1982; 91: 631.
5. Hayashi T, Nagasue N, Kohno H, Chang YC, Nakamura T. Beneficial effect of cyclosporine pretreatment in canine liver ischemia. Transplantation 1991; 52: 116.
6. 2 treatment. Am J Physiol 1985; 248: H804.
7. Chazouillères O, Ballet F, Chrétien Y, et al. Protective effect of vasodilators on liver function after long hypothermic preservation: a study in the isolated perfused rat liver. Hepatology 1989; 9: 824.
8. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40: 584.
9. Uchida M, Takemoto Y, Nagasue N, Dhar DK, Kohno H, Nakamura T. Effect of verapamil on hepatic reperfusion injury after Prolonged ischemia in pigs. J Hepatol 1994; 21: 217.
10. Nordström G, Seeman T, Hasseigren P-O. Beneficial effect of allopurinol in liver ischemia. Surgery 1985; 97: 679.
11. Chien KR, Abrams J, Pfau RG, Farber JL. Prevention by chlorpromazine of ischemic liver cell death. Am J Pathol 1977; 88: 539.
12. Dhar DK, Nagasue N, kimoto T, Uchida M, Takemoto Y, Nakamura T. The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. Transplantation 1992; 54: 583.
13. Mittal MK, Gupta TK, Lee F-Y, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267: G416.
14. Nishida J, McCuskey RS, McDonnell D, Fox ES. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994; 267: G1135.
15. Shiraishi M, Kusano T, Aihara T, Ikeda Y, koyama Y, Muto Y. Protection against hepatic ischemia/reperfusion injury by exogenous L-arginine. Transplant Proc 1996; 28: 1887.
16. Jones SM, Thurman RG. L-Arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996; 24: 163.
17. Peralta C, Hotter G, Closa D, Gelpí E, Bulbena O, Rosell-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934.
18. Siraishi M, Hiroyasu S, Nagahama M, et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 1997; 69: 429.
19. Koeppel TA, Thies JC, Schemmer P, et al. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997; 27: 163.
20. Längle F, Roth E, Steininger R, Winkler S, Mühlbacher F. Arginase release following liver reperfusion: evidence of hemodynamic action of arginase infusions. Transplantation 1995; 59: 1542.
21. Hino M, Iwami M, Okamoto M, et al. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1989; 42: 1578.
22. Isono T, Koibuchi Y, Sato N, et al. Vasorelaxant mechanism of the new vasodilator, FK409. Eur J Pharmacol 1993; 246: 205.
23. Kita Y, Hirasawa Y, Yoshida K, Maeda K. Antiplatelet activities of FK409, a new spontaneous NO releaser. Br J Pharmacol 1994; 113: 385.
24. Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol 1994; 257: 123.
25. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993; 214: 11.
26. Almond NE, Wheatley AM. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 1992; 262: G203.
27. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265.
28. Schmid-Schönbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987; 46: 2397.
29. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262: H616.
30. Saito A, Matsuno N, Kozaki K, et al. Changes in plasma nitrite/ nitrate level after orthotopic liver transplantation in pigs. Transplant Proc 1996; 28: 1761.
31. Blebea J, Bacik B, Strothman G, Myatt L. Decreased nitric oxide production following extremity ischemia and reperfusion. Am J Surg 1996; 172: 158.
32. Geller DA, Nussler AK, Di Silvio M, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522.
33. Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res 1996; 63: 501.
34. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996; 27: 1373.
35. Kita Y, Fukuyama S, Hirasawa Y. Close correlation between nitric oxide (NO) formation from NO releasers and the biological activities of these agents in rats. Jpn J Pharmacol 1995; 69: 69.
36. Isono T, Sato N, Yamamoto T, et al. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409. Eur J Pharmacol 1994; 260: 163.
37. Kita Y, Ohkubo K, Hirasawa Y, et al. FR144420, a novel, slow, nitric oxide releasing agent. Eur J Pharmacol 1995; 275: 125.
38. Kita Y, Sugimoto T, Hirasawa Y, Yoshida K, Maeda K. Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level. Br J Pharmacol 1994; 113: 5.
39. Cywes R, Packham MA, Tietze L, et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993; 18: 635.
40. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355.
41. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355.
42. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukocyte Biol 1992; 52: 377.
43. Davies MG, Fulton GJ, Hagen P-O. Clinical biology of nitric oxide. Br J Surg 1995; 82: 1598.
44. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481.
45. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991; 260: C910.
46. Curran RD, Billiar TR, Stuehr DJ, et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990; 212: 462.
47. Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 1991; 179: 442.